TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

LOG IN / REGISTER

LOG IN

Don’t have an account? Register here Give your organization full access to The Jakarta Post. Register here

Sinovac-Biotech

National 5 years ago

More Sinovac candidate vaccine doses arrive

An additional 1.8 million doses of Sinovac Biotech's COVID-19 candidate vaccine arrived at Soekarno-Hatta International Airport on Thursday.

National 5 years ago

Sinovac vaccine compatible with certain comorbidities: PAPDI

“This recommendation is specifically created for the COVID-19 Sinovac vaccine, and is subject to change as the clinical trials progress,” said the association in the letter, a copy of which was obtained by The Jakarta Post on Saturday.

National 5 years ago

Sinovac vaccine has no critical side effects, BPOM says

Indonesia has firm orders of around 160 million vaccine doses, of which 140 million are manufactured by Sinovac Biotech.

Business 5 years ago

PREMIUM
World Bank cuts Indonesia’s GDP forecast, saying public health key to recovery

The World Bank has slashed Indonesia's economic growth projection for this year as the government struggles to control the pandemic.

National 5 years ago

Bio Farma allocates 3 million doses of COVID-19 vaccine for health workers

According to Honesti, 568 out of 1.2 million vials had been set aside for a quality check conducted by Bio Farma and the Indonesian Food and Drug Monitoring Agency (BPOM).

National 5 years ago

Indonesia greenlights adoption of major COVID-19 vaccines

As countries begin taking the leap by approving the use of candidate vaccines to fight the pandemic, the Indonesian government issued on Friday a decree to allow for the use of vaccines currently being developed by certain drugmakers.

Health 5 years ago

Stages of COVID-19 vaccine development: Where do we stand?

In Indonesia, a potential vaccine developed by Chinese biopharmaceutical company Sinovac Biotech entered the phase III clinical trials in August.

National 5 years ago

Govt gears up for future COVID-19 vaccination

The government has drafted scenarios and prepared logistical needs necessary to distribute COVID-19 vaccine across the archipelago, to make sure it can be evenly disbursed once available.

Opinion 5 years ago

Why the COVID-19 vaccine should be mandatory

The question is: Once vaccines hit the market, what then? From the perspective of maximum social welfare, everyone should be vaccinated.

World 5 years ago

Government, Bio Farma secure vaccine bulk supply from China's Sinovac

In her first overseas visit in six months, the Indonesian foreign minister led a delegation to secure priority access to Sinovac Biotech's COVID-19 vaccine bulk.

TheJakartaPost

Popular Reads

Top Results

Popular Reads

Top Results

LOG IN

Sinovac-Biotech

More Sinovac candidate vaccine doses arrive

Sinovac vaccine compatible with certain comorbidities: PAPDI

Sinovac vaccine has no critical side effects, BPOM says

PREMIUM World Bank cuts Indonesia’s GDP forecast, saying public health key to recovery

Bio Farma allocates 3 million doses of COVID-19 vaccine for health workers

Indonesia greenlights adoption of major COVID-19 vaccines

Stages of COVID-19 vaccine development: Where do we stand?

Govt gears up for future COVID-19 vaccination

Why the COVID-19 vaccine should be mandatory

Government, Bio Farma secure vaccine bulk supply from China's Sinovac

follow our Social media

PREMIUM
World Bank cuts Indonesia’s GDP forecast, saying public health key to recovery